Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study

References

• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317(24):2515–2523. doi:10.1001/jama.2017.7596
   PubMed Web of Science ®Google Scholar
• Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes. 2018;67(1):3–11. doi:10.2337/dbi17-0013
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S73–S85. doi:10.2337/dc18-S008.
   PubMed Web of Science ®Google Scholar
• Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, Del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 2016;7(17):354–395. doi:10.4239/wjd.v7.i17.354
   PubMed Web of Science ®Google Scholar
• Fu AZ, Sheehan JJ. Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control. Curr Med Res Opin. 2017;33(5):853–858. doi:10.1080/03007995.2017.1292231
   PubMed Web of Science ®Google Scholar
• Society CD.Chinese guideline for the prevention and treatment of type 2 diabetes mellitus (2017 edition). Chin J Diabetes Mellitus. 2018;10(1):4–67.
   Google Scholar
• Khunti K, Gomes MB, Pocock S, et al. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab. 2018;20(2):427–437. doi:10.1111/dom.13088
   PubMed Web of Science ®Google Scholar
• Khunti K, Millar-Jones D. Clinical inertia to insulin initiation and intensification in the UK: a focused literature review. Prim Care Diabetes. 2017;11(1):3–12. doi:10.1016/j.pcd.2016.09.003
   PubMed Web of Science ®Google Scholar
• Reach G, Pechtner V, Gentilella R, Corcos A, Ceriello A. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab. 2017;43(6):501–511. doi:10.1016/j.diabet.2017.06.003
   PubMed Web of Science ®Google Scholar
• Wang X, He Y, Wang T, et al. Lipid-lowering therapy and low-density lipoprotein cholesterol (LDL-C) goal achievement in high-cardiovascular-risk patients in Fuzhou, China. J Cardiovasc Pharmacol Ther. 2020;1074248419899298. doi:10.1177/1074248419899298.
   Google Scholar
• Ruiz-Negrón N, Wander C, McAdam-Marx C, Pesa J, Bailey RA, Bellows BK. Factors associated with diabetes-related clinical inertia in a managed care population and its effect on hemoglobin A1c goal attainment: a claims-based analysis. J Manag Care Spec Pharm. 2019;25(3):304–313. doi:10.18553/jmcp.2019.25.3.304
   PubMedGoogle Scholar
• Matsumoto T, Ohnishi H, Sato T, et al. Insulin resistance is associated with longitudinal changes of cardiac repolarization heterogeneity in apparently healthy subjects. Cardiol Ther. 2019;8(2):239–251. doi:10.1007/s40119-019-0140-7
   PubMedGoogle Scholar
• Yu S, Schwab P, Bian B, Radican L, Tunceli K. Use of add-on treatment to metformin monotherapy for patients with type 2 diabetes and suboptimal glycemic control: A U.S. database study. J Manag Care Spec Pharm. 2016;22(3):272–280. doi:10.18553/jmcp.2016.22.3.272
   PubMedGoogle Scholar
• Goodall G, Sarpong EM, Hayes C, Valentine WJ. The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study. BMC Endocr Disord. 2009;9:19. doi:10.1186/1472-6823-9-19
   PubMed Web of Science ®Google Scholar
• Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med. 2007;24(12):1412–1418. doi:10.1111/j.1464-5491.2007.02279.x
   PubMed Web of Science ®Google Scholar
• Nichols GA, Koo YH, Shah SN. Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. J Gen Intern Med. 2007;22(4):453–458. doi:10.1007/s11606-007-0139-y
   PubMed Web of Science ®Google Scholar
• Jabbar A, Mohamed WMIBW, Ozaki R, et al. Patterns and trends in insulin initiation and intensification among patients with type 2 diabetes mellitus in the Western Pacific region. Curr Med Res Opin. 2018;34(9):1653–1662. doi:10.1080/03007995.2018.1484712
   PubMed Web of Science ®Google Scholar
• Jabbar A, Abdallah K, Hassoun A, et al. Patterns and trends in insulin initiation and intensification among patients with type 2 diabetes mellitus in the Middle East and North Africa region. Diabetes Res Clin Pract. 2019;149:18–26. doi:10.1016/j.diabres.2019.01.017
   PubMed Web of Science ®Google Scholar
• Romanelli RJ, Chung S, Pu J, Nimbal V, Zhao B, Palaniappan L. Comparative effectiveness of early versus delayed metformin in the treatment of type 2 diabetes. Diabetes Res Clin Pract. 2015;108(1):170–178. doi:10.1016/j.diabres.2014.12.019
   PubMedGoogle Scholar
• Mata-Cases M, Franch-Nadal J, Real J, et al. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: factors predicting intensification of treatment. Diabetes Obes Metab. 2018;20(1):103–112. doi:10.1111/dom.13045
   PubMedGoogle Scholar
• Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–3417. doi:10.2337/dc13-0331
   PubMed Web of Science ®Google Scholar
• Calvert MJ, McManus RJ, Freemantle N. Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study. Br J Gen Pract. 2007;57(539):455–460.
   PubMed Web of Science ®Google Scholar
• Mashitisho MLI, Mashitisho BG. Early insulin therapy in patients with type 2 diabetes mellitus. J Endocrinol Metabol Diabetes S Af. 2016;21(1):13–15. doi:10.1080/16089677.2016.1160539
   Web of Science ®Google Scholar
• Bhattacharya R, Zhou S, Wei W, Ajmera M, Sambamoorthi U. A real-world study of the effect of timing of insulin initiation on outcomes in older medicare beneficiaries with type 2 diabetes mellitus. J Am Geriatr Soc. 2015;63(5):893–901. doi:10.1111/jgs.13388
   PubMedGoogle Scholar
• McEwen LN, Bilik D, Johnson SL, et al. Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD). Diabetes Care. 2009;32(6):971–976. doi:10.2337/dc08-1911
   PubMedGoogle Scholar
• Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab. 2016;18(4):401–409. doi:10.1111/dom.12626
   PubMed Web of Science ®Google Scholar
• Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med. 2007;5(3):196–201. doi:10.1370/afm.679
   PubMed Web of Science ®Google Scholar
• Chaudhry SI, Berlowitz DR, Concato J. Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus? J Am Geriatr Soc. 2005;53(7):1214–1216. doi:10.1111/j.1532-5415.2005.53370.x
   PubMedGoogle Scholar
• Schwab P, Saundankar V, Bouchard J, et al. Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs. BMJ Open Diabetes Res Care. 2016;4(1):e000099. doi:10.1136/bmjdrc-2015-000099
   PubMed Web of Science ®Google Scholar
• Vitry AI, Roughead EE, Preiss AK, et al. Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One. 2010;5(11):e14024. doi:10.1371/journal.pone.0014024
   PubMedGoogle Scholar
• Khunti S, Davies MJ, Khunti K. Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review. Br J Diabetes. 2015;15(2):65–69. doi:10.15277/bjdvd.2015.019
   Web of Science ®Google Scholar
• Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371–380. doi:10.2147/DMSO.S120101
   PubMed Web of Science ®Google Scholar